Open AccessFeasibility, results and endoscopic requirements of the Elipse� swallowable intragastric balloon: initial experience
Author(s) -
Eduardo Espinet Coll,
Sonia Carrasco Clavijos,
Patricia Díaz Galán,
C Vila Lolo,
José Antonio Gómez Valero,
S Bacchiddu,
Daniel Irigoyen,
Teresa Durán Pastor,
Laura Mora Cubells,
A Juan-Creix Comamala
Publication year - 2019
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2019.6340/2019
Subject(s) - medicine , balloon , weight loss , capsule , adverse effect , capsule endoscopy , surgery , endoscopy , gastroenterology , obesity , botany , biology
the Elipse® intragastric balloon (EIGB) is a swallowable capsule that is filled under x-ray control. After 16 weeks, its self-releasing valve is degraded and the balloon is deflated and excreted naturally, without endoscopy. The aim of this study was to assess the feasibility of EIGB and its efficacy, duration, safety and endoscopic requirements.